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Are low-value care measures up to the
task? A systematic review of the literature
Eline F. de Vries1*, Jeroen N. Struijs2, Richard Heijink2, Roy J. P. Hendrikx1 and Caroline A. Baan1,2
Abstract
Background: Reducing low-value care is a core component of healthcare reforms in many Western countries. A
comprehensive and sound set of low-value care measures is needed in order to monitor low-value care use in
general and in provider-payer contracts. Our objective was to review the scientific literature on low-value care
measurement, aiming to assess the scope and quality of current measures.
Methods: A systematic review was performed for the period 2010–2015. We assessed the scope of low-value care
recommendations and measures by categorizing them according to the Classification of Health Care Functions.
Additionally, we assessed the quality of the measures by 1) analysing their development process and the level of
evidence underlying the measures, and 2) analysing the evidence regarding the validity of a selected subset of the
measures.
Results: Our search yielded 292 potentially relevant articles. After screening, we selected 23 articles eligible for
review. We obtained 115 low-value care measures, of which 87 were concentrated in the cure sector, 25 in
prevention and 3 in long-term care. No measures were found in rehabilitative care and health promotion. We
found 62 measures from articles that translated low-value care recommendations into measures, while 53 measures
were previously developed by institutions as the National Quality Forum. Three measures were assigned the highest
level of evidence, as they were underpinned by both guidelines and literature evidence. Our search yielded no
information on coding/criterion validity and construct validity for the included measures. Despite this, most
measures were already used in practice.
Conclusion: This systematic review provides insight into the current state of low-value care measures. It shows that
more attention is needed for the evidential underpinning and quality of these measures. Clear information about
the level of evidence and validity helps to identify measures that truly represent low-value care and are sufficiently
qualified to fulfil their aims through quality monitoring and in innovative payer-provider contracts. This will contribute
to creating and maintaining the support of providers, payers, policy makers and citizens, who are all aiming to improve
value in health care.
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Background
The concept of low-value care, defined as services that
provide no benefit to patients or can even cause harm
[1], has received much attention in recent years in West-
ern countries. Reducing the use of low-value care is ex-
pected to contribute to cost containment and more
efficiency in health care [2–4]. It leads to a reduction in
medical spending without harming health outcomes and
it may stimulate a reallocation of resources to high-value
services [3]. In this way, measuring low-value care for
which the non-effectiveness is proven provides informa-
tion on a specific type of inefficiency, i.e. spending with
no benefit, which can be used besides other, more indir-
ect, types of efficiency analysis such as traditional cost-
effectiveness studies or analyses of practice variation.
Internationally, several initiatives have been launched
to reduce low-value service utilization, among which the
Choosing Wisely (CW) campaign in the US. Similar
initiatives have originated in 12 other countries includ-
ing the United Kingdom, Canada, Australia and the
Netherlands [3, 5]. In the CW campaign, participating
specialty societies produce lists of recommendations that
are to be discussed in the doctor’s office, as for example,
‘don't order diagnostic tests at regular intervals (such as
every day), but rather in response to specific clinical
questions’ [6]. Ideally, these lists of recommendations
would meet the CW criteria: 1) each of the services is
within the specialty’s purview, 2) each of the services is
frequently used or costly, 3) each recommendation is
based on sufficient evidence, and 4) the process for de-
veloping the recommendation list is documented and is
made available to the public if requested [7]. In general,
the recommendations aim to increase awareness among
both doctors and patients [4] and subsequently influence
the decision whether or not to use a specific service.
Besides these rather generic recommendations, studies
have tried to assess the prevalence and geographic or
practice variation in low-value care utilization (e.g. [8–
11]) using direct measures of low-value care. The aim of
the direct measures differs from the aim of recommen-
dations. Where recommendations aim to create aware-
ness among physicians and patients, low-value care
measures may be widely used, for example in payer-
provider contracts [12, 13] and for monitoring low-value
care initiatives [3, 14].
To meet these aims, low-value care measures need to
be methodologically sound [15, 16]. Otherwise, using
these measures might create misinterpretation, underuse
of indicated services, patient selection or damage the
patient-physician relationship [17]. To date, only one
study [18] reviewed the state of low-value care measure-
ment by performing a scan of the published and grey lit-
erature. They found 37 specified measures and 123
services that may be developed into measures, covering
mainly diagnostic or therapeutic areas. Furthermore, an-
other study [19] identified a set of low-value services
and demonstrated significant variance in its utilization
between hospital referral regions in the US.
Still, major knowledge gaps exist in the literature on
measuring low-value care. First, there is lack of know-
ledge regarding the validity of current low-value care
measures [15, 16]. As Baker et al. [14] pointed out earl-
ier, low-value care measures must at least be rigorously
evidence-based. In addition, they must be able to detect
variation between providers, regions or countries, reflect
actual cases of the concept of interest, be supported by
correlations to other measures indicating the same con-
cept, and not be subject to substantive systemic bias (i.e.
importance, coding or criterion validity, construct valid-
ity and risk adjustment) [20]. Therefore, specific stan-
dards for how to develop and assess low-value care
measures should be developed [14, 17]. Second, it is un-
clear whether current low-value care measures cover the
whole continuum of care. This is important, because it
was argued that low-value care use is present in all sec-
tors along the care continuum [14, 21]. However, the
low-value service recommendations from the CW initia-
tive cover mainly specialist care in the cure sector [7].
In this study, we aimed to start filling these gaps by per-
forming a systematic review of the recent scientific litera-
ture on low value care measurement. Our objective was
twofold. Firstly, to assess the scope of low-value care rec-
ommendations and measures in the literature by categor-
izing them according to health care function (such as
curative care, long-term care and rehabilitation). Secondly,
to assess the quality of the measures by 1) analysing their
development process and the evidence that underlies the
measures and 2) analysing the evidence regarding the val-
idity of a selection of the included measures.
Methods
Study design and search strategy
A systematic review of the literature was performed, fo-
cusing on English-language articles published between
January 2010 and January 2015. As recommended by
Cochrane [22], we performed our search in multiple da-
tabases including EMBASE, Medline, SciSearch, BIOSIS
Previews and GLOBAL Health. We developed a search
strategy to identify articles matching a variation of the
following search terms: 1) initiatives, design, measuring,
indicators, instrument, identifying, index; 2) waste, over-
use, overutilization, misuse, low-value; and 3) health
care, cure, care, prevention. Additional file 1 gives a de-
tailed description of the search strategy.
Article selection
Two researchers (EFdV & RJPH) independently reviewed
the relevance of the articles by screening titles and
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abstracts. As recommended by Cochrane [22], we in-
cluded articles from peer-reviewed journals only. The
full-text was retrieved when both researchers considered
the paper relevant. Articles were eligible for review when
they met the following predefined criteria: 1) the low-
value service recommendation or measure in the paper
matched the definition ‘services that provide no benefit
to patients or may even cause harm [1]’; 2) the low-
value service recommendation or measure was described
using clinical details such as diagnosis, patient popula-
tion and treatment. We removed duplicate articles and
replies or commentaries and theoretical or discussion ar-
ticles that did not present any low-value service recom-
mendations or measures. Any disagreement between the
reviewers was resolved by discussion and consensus.
Data extraction
We extracted general characteristics of the articles (i.e.
name of first author, year of publication, country, aim of
the paper, methods) and the measures (i.e. the name of
the measure, the numerator, the denominator, exclusion
criteria and direction). In addition, we retrieved the ori-
ginal source or reference of the measure.
Recommendations versus measures
The literature search yielded both recommendations and
measures for low-value care. We considered a descrip-
tion of low-value care as ‘measure’ when at least a nu-
merator and denominator were specified as such. We
identified the scope of both recommendations and mea-
sures, while the quality assessment was performed for
the measures only.
Categorizing low-value care recommendations and
measures by function in health care
All recommendations and measures were categorized
using the Classification of Health Care Functions
(ICHA-HC) as defined by the Organization for Eco-
nomic Co-operation and Development (OECD), the
World Health Organization (WHO) and Eurostat [23].
The ICHA-HC provides a framework to classify services
according to their purpose or function and is commonly
used to compare medical services internationally. It
covers the entire continuum of the health system, i.e.
curative care, rehabilitative care, long-term care and pre-
ventive care. We subcategorized curative care into gen-
eral (i.e. primary) care and specialized care. General care
involves basic care such as routine examinations, basic
maternity care, routine diagnosis and follow-up, pre-
scriptions and vaccinations (unless they are covered
under a preventive program) [23]. Specialized care in-
volves more complex technology and is often a break-
down from the basic fields (e.g. neurosurgery or
allergology) [23]. In addition, the measures were
categorized according to the non-functional categories
ancillary services (i.e. laboratory, imaging, transport),
and medical goods (i.e. pharmaceutical and therapeutic
appliances).
Assessing the quality of low-value care measures
We assessed the quality of the measures by 1) analysing
their development process and the level of evidence
underlying the measures, and 2) analyse the validity of a
selection of the measures.
Development process and level of evidence
We distinguished two groups: A) articles that translated
low-value service recommendations into low-value care
measures, and B) articles that used measures previously
developed by institutions. For both groups we reviewed
how the measures were developed.
For group A, we searched for evidence underlying the
recommendations. We categorized each measure based
on the evidence, distinguishing three levels of evidence:
1) a combination of evidence from the literature (trial
or review), guidelines and from CW, United States Pre-
ventive Services Task Force (USPSTF) or National In-
stitute of Clinical Excellence (NICE) recommendations,
2) evidence from the literature (trial or review) or
guidelines, and 3) evidence not found. As criteria for
developing CW recommendations do not prescribe the
level of evidence required [7] we labelled measures with
CW, USPSTF or NICE evidence only, as ‘unknown’.
We valued the first level highest, and the third level
lowest.
For group B, we distinguished the same levels of evi-
dence. However, here we specifically searched for ele-
ments of a quality label indicating the soundness of the
measure. A National Quality Forum (NQF) endorsement
corresponds with the qualification of ‘minor or no evi-
dence gaps’ [20]. Measures with such qualification have
the strongest evidence base regarding importance, face
validity, criterion validity, construct validity and risk ad-
justment [20]. Therefore, NQF endorsed measures were
valued highest. The Agency of Healthcare Research and
Quality (AHRQ) and the Centers of Medicare and Me-
dicaid Services’ (CMS) Quality provide information on
the level of evidence by specifying the literature under-
pinning the measure. Therefore, measures from these
sources were valued second best.
For both groups, our assessment was limited to the
evidence provided in the reviewed article and the first
document retrieved by reference tracking.
Validity
We selected a subset of five unique measures in order to
gain insight in the quality of the low value care mea-
sures. Ideally, we would extensively assess each measure
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regarding their validity. However, for 115 measures this
was beyond the scope of this review. Therefore, we
chose five unique measures that appeared most fre-
quently in the reviewed articles, assuming more infor-
mation on validity to be available for these measures.
For these five measures, we searched for evidence re-
garding the measures’ validity by reviewing the original
source and reference tracking. In addition, we performed
a PubMed search using key words from the name of the
measures (i.e. diagnosis and procedure) and “low-value”
or “overuse”, augmented with “validity”. Specifically, we
searched for studies that aimed to assess the validity of
the selected low-value care measures. Hereby, we distin-
guished between the most commonly used types of val-
idity (as seen in e.g. [20, 24, 25]): face validity, coding/
criterion validity (i.e. reflect actual cases low-value care)
and construct validity (i.e. supported by correlations to
other measures indicating low-value care) [20]. Face val-
idity refers to the empirical or clinical rationale of the
measure, and therefore we used the information from
Table 2 for this criterion.
Results
Article retrieval
Our literature search yielded 292 potentially relevant ar-
ticles (Fig. 1). Based on titles and abstracts, 108 articles
were selected for full-text retrieval and thorough screen-
ing. This screening process generated 23 articles that
were eligible for review. Main reasons for exclusion were
using a different definition of low-value care (n = 138),
for example articles on garbage, patient safety or drug
abuse, or not providing clinical details (n = 49). Figure 1
shows all reasons for exclusion.
Article characteristics
All articles were published after 2011 and the vast ma-
jority of the 23 included articles originated from the
United States (n = 22) (Table 1). Seven articles explicitly
focused on low-value care measures. One of these
reviewed the literature on low-value care measurement
[18], and six were empirical studies measuring low-value
care utilization [2, 8, 10, 11, 19, 26]. Low-value care
Fig. 1 Flow chart summarizing article selection
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Table 1 General characteristics of the included articles (n = 23)
First author Year of
publication





2013 US To identify five services that physicians and patients
should question.
Review + Delphi/consensus 0 5 CW
AGS Choosing Wisely
Workgroup [34]
2014 US To identify another five services that physicians and
patients should question.
Delphi/consensus 0 5 CW
Amos [35] 2015 US To determine the prevalence of PIMs for older adults in
Elimia-Romagna, Italy, using updated Maio criteria.
Empirical analysis 0 16 Other
Bulger [36] 2013 US To identify five services that physicians and patients
should question.
Review + Delphi/consensus 0 5 CW
Chan [18] 2013 US To describe and critique the current state of overuse
measurement.
Review 37 122 Other
Colla [8] 2015 US To develop claims-based algorithms to estimate the
prevalence of Choosing Wisely services and to examine
the demographic, health and health care system
correlates of low-value care at a regional level.
Empirical analysis 11 0 N.A.
Elshaug [37] 2012 AUS To develop and apply a novel method for scanning a
range of sources to identify existing health care
services (excluding pharmaceuticals) that have
questionable benefit, and produce a list that warrant
further investigation.
Review 0 174 Other
Halpern [38] 2014 US To present the Critical Care Societies Collaborative top
5 list in Critical Care Medicine and describe its
development.
Review + Delphi/consensus 0 5 CW
Hicks [39] 2013 US To identify five services that physicians and patients
should question.
Review + Delphi/consensus 0 5 CW
Kale [26] 2013 US The objective of this study was to determine whether
the overuse and misuse of health care services in the
ambulatory setting has decreased in the past decade.
Empirical analysis 13 0 N.A.
Keyhani [40] 2013 US To compare rates of overuse in different health care
systems and examine whether certain systems of care
or insurers have lower rates of overuse of health care
services.
Systematic review 0 7 Other
Korenstein [41] 2012 US To perform an extensive search for studies of overuse
of therapeutic procedures, diagnostic tests, and
medications in the United States and describe the state
of the literature.
Extensive search 0 33 Other
Mathias [10] 2012 US To characterize performance on imaging-use measures,
determine whether performance was consistent across
measures, and identify hospital characteristics associated
with highest-decile imaging use.
Empirical analysis 4 0 N.A.
Morden [11] 2014 US To measure the prevalence and describe the geographic
variation of short-interval (repeated in under 2 years)















Table 1 General characteristics of the included articles (n = 23) (Continued)
DXAs among Medicare beneficiaries and estimated the
cost of this testing and its responsiveness to payment
change.
Onuoha [42] 2014 US To develop a top 5 list of unnecessary medical services
in anesthesiology.
Review + Delphi/consensus 0 5 CW
Quinonez [43] 2013 US To produce top 5 lists. Review + Delphi/consensus 0 5 CW
Rouster-Stevens [44] 2014 US To create a pediatric rheumatology Top 5 list as part of
the American Board of Internal Medicine Foundation’s
Choosing Wisely campaign.
Review + Delphi/consensus 0 5 CW
Schuur [45] 2014 US To create a top-five list of tests, treatments, and
disposition decisions that are of little value, are
amenable to standardization, and are actionable by
emergency medicine clinicians.
Delphi/consensus 0 5 CW
Schwartz [2] 2014 US To develop claims-based measures of low-value
services, examine service use (and associated spending)
detected by these measures in Medicare, and
determine whether patterns of use are related across
different types of low-value services.
Empirical analysis 26 0 N.A.
Segal [19] 2014 US To identify a set of possible indicators of overuse that
can be operationalized with claims data and to
describe variation in these indicators across the hospital
referral regions (HRRs).
Empirical analysis 20 0 N.A.
Wiener [46] 2014 US To create a top 5 list. Review + Delphi/consensus 0 5 CW
Williams [47] 2012 US To present the final five Choosing Wisely Don’t do
recommendations, the rationale for these specific
recommendations, and two other recommendations.
Delphi/consensus 0 5 CW
Wood [48] 2013 US To report on the CW top 5 list. Review + Delphi/consensus 0 5 CW
AGS American Geriatrics Society, AUS Australia, CW Choosing Wisely, N.A. Not Applicable, PIM Potentially Inappropriate Medications, US United States















recommendations were presented in 17 articles of which
most were related to the CW campaign (n = 12).
Our search yielded 115 low-value care measures and
412 low-value care recommendations. Additional file 2
shows the characteristics of the 115 low-value care mea-
sures (i.e. containing a numerator and denominator).
Out of these 115 measures, 42 contained exclusion cri-
teria. For one of these measures (measure no. 72,
Additional file 2), the direction of the measure was spe-
cified. Additional file 3 lists all recommendations (i.e.
not containing numerator and/or denominator).
Low-value care recommendations and measures by
function in health care
Figure 2 displays an overview of low-value care recom-
mendations and measures categorized by health care func-
tion [23]. Here, we combined recommendations and
measures covering the same combination of diagnosis and
procedure. For instance, we found 8 measures for imaging
in low back pain (measure no. 2–9, Additional file 2) using
slightly varying exclusion criteria regarding e.g. age cat-
egory (18–50 years versus 18–55 years) or intervention
(imaging in general versus specific MRI). These eight mea-
sures were combined into a single group. In this manner,
we found that 115 measures and 101 low-value care rec-
ommendations corresponded with 65 measure groups.
The remaining recommendations (n = 412-101 = 311)
were aggregated into 241 new recommendation groups.
In the cure dimension we found 87 measures, which
we further subdivided in general care (n = 85) and spe-
cialized care (n = 2). Most measures in the cure di-
mension were in imaging (n = 50) or pharmaceutical
goods (n = 15). The remaining measures were catego-
rized in long-term care (n = 3) and secondary preven-
tion (n = 25).
Quality of low-value care measures
Development process
Approximately half of the measures (n = 62) originated
from low-value care recommendations (group A). Al-
though the authors of the articles [2, 8, 11, 19, 26] de-
scribed the methods to operationalize the low-value care
measures, it was not specifically described how each spe-
cific low-value care recommendation was translated into
a measure, i.e. how the denominator, numerator, exclu-
sion and direction were determined for the purpose of
the study. We did find that the measures developed by
clinicians (n = 18) [8, 19] used (a combination of ) Inter-
national Classification of Diseases (ICD-9) and/or
current procedural terminology (CPT) codes to con-
struct the denominator [8, 19, 26].
The other half of the measures (n = 54) were devel-
oped by institutions (group B), including the NQF (n =
25) [8, 18, 19], the AHRQ (n = 10) [18, 19, 26], CMS
QualityNet (n = 16) [10, 18, 19] and Blue Cross Blue
Shield (n = 2) [19].
Fig. 2 Number of low-value care recommendations and measures categorized by the OECD/WHO/Eurostat Classification of Health Care Functions
(n = 426)*. Admin.: Administrative; Alternative: Traditional, Complementary and Alternative Medicine; LTC: Long Term Care; Rehab.: Rehabilitative
care; *We yielded 115 low-value care measures and 412 recommendations from the literature. Since 101 recommendations had a similar subjects
as the measures, we subtracted these from 412 recommendations. That leaves 311 recommendations. Therefore, the total recommendations and
measures in figure is 311 + 101 = 426
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Level of evidence
Table 2 shows the level of evidence provided in the ref-
erenced sources for each measure. In group A, the rec-
ommendations were mainly derived from CW, USPSTF,
and NICE (n = 45). Other group A measures originated
from guidelines, peer-reviewed literature or sources that
summarized low-value services [27].
Three measures (measure no. 39, 40, 46; Additional
file 2) were assigned the highest level of evidence (1), as
they were underpinned by guidelines and literature (trial
or review) and recommendations. For most measures (n
= 33), however, we found guideline or literature evidence
solely. For one measure (measure no. 101) the USPSTF
considered the evidence for the underlying recommen-
dation insufficient to assess the benefits and harms of
the procedure, which we therefore assigned with the
lowest level of evidence. At the time of our review, for
24 measures, we considered the level of evidence to be
unknown.
In group B, we found 19 measures [8, 18] supported
by a quality label (NQF). For six measures the NQF en-
dorsement was removed (n = 4) or not found (n = 2). Al-
though the AHRQ website provides detailed information
on the measures, we found no quality label, such as the
NQF endorsement. We found seven measures (measure
no. 1, 4, 55, 60, 69, 70, 86) displaying measurement char-
acteristics (e.g. domain (process/outcome), description
of denominator and numerator and target population)
and evidence supporting the measure. The measures de-
rived from QualityNet [28] were described in detail,
however, no evidence supporting the description was
provided.
Table 2 Level of evidence of low-value care measures
Level of evidence Group A: Recommendation source Measure numbersa Count
1 CW, NICE or USPSTF recommendations;
Guideline;
Literature evidence (review or clinical trial)
39, 40, 46 3
2 CW, NICE or USPSTF recommendations;
Literature evidence (review or clinical trial)
13, 14, 19, 20, 22, 23, 24, 25, 26, 44, 48, 50, 55,
77, 80, 90, 95, 103, 112, 115
20
2 CW, NICE or USPSTF recommendations;
Guideline
33, 53 2
2 Literature evidence (reviews or clinical trial) 3, 21, 58, 76, 78, 81, 82, 83, 85, 89 10
2 Guideline 54, 57 2
3 USPSTF concludes that evidence is insufficient 101 1
Unknown Literature: other compiled low-value service lists 47, 49, 113 3
Unknown USPSTF recommendation not found 104, 107 2
Unknown CW, NICE or USPSTF recommendations 34, 38, 43, 45, 51, 52, 59, 61, 84, 92, 98, 102, 105,
106, 108, 109, 110, 111, 114
19
Level of evidence Group B: Institutional measure status Measure numbersa
1 NQF endorsed 5, 11, 16, 18, 41, 56, 62–67, 72, 73, 91, 93, 94,
96, 97
19
2 AHRQ measure supported by a clinical practice guideline or
other peer-reviewed synthesis of clinical research evidence
and one or more research studies published in a National
Library of Medicine (NLM) indexed, peer-reviewed journal
60, 69, 70 3
2 AHRQ measure supported by a clinical practice guideline or
other peer-reviewed synthesis of the clinical research evidence
1, 4, 55, 86 4
2 CMS QualityNet 2, 7, 8, 9, 27, 28, 29, 30, 31, 32, 37, 42, 99, 100 14
3 NQF endorsement removed since April 2014 6, 10, 74, 75 4
Unknown NQF endorsement not found 17, 71 2
Unknown AHRQ measure/guideline not found 68, 79, 87 3
Unknown CMS QualityNet under revision 15 1
Unknown CMS not found 12 1
Unknown BCBS AQC measures not found 35, 36 2
AHRQ Agency for Healthcare Research and Quality, BCBS AQC Blue Cross Blue Shield, The Alternative Quality Contract, CMS Centers for Medicare & Medicaid
Services, CW Choosing Wisely, IOM Institute of Medicine, NICE National Institute for Clinical Excellence (UK): do not do recommendations, NQF National Quality
Forum, USPSTF United States Preventive Services Task Force
a: measure numbers are in correspondence with Additional file 2
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Validity
Table 3 shows the validity of the five measures that were
found most frequently (n = 26). Two measures had the
highest level of evidence. Our search yielded no informa-
tion on coding/criterion validity and construct validity
for the included measures, while four out of five mea-
sures are currently used in practice.
Discussion
To the best of our knowledge, this is the first systematic
literature review identifying, categorizing and assessing
the scope and quality of low-value care measures. We
obtained 115 low-value care measures from the litera-
ture. Out of these 115 measures, 87 focused on the cure
sector (primary and specialized care), 25 on secondary
prevention and 3 on long-term care. Most measures (n
= 62) originated from low-value care recommendations,
while 53 were previously developed by institutions as the
National Quality Forum. Three measures were assigned
the highest level of evidence, as they were underpinned
by both guidelines and literature evidence. For other
measures, such a level of evidence was not transparently
apparent. We do not conclude that these measures are
invalid, because validity tests may not have been per-
formed at all. Nevertheless, a lack of evidence is present
at least. Our search yielded no information on coding/
criterion validity and construct validity for the included
subset of measures in this emerging field. Despite this,
most measures are currently used in practice.
Low-value care measures have received increased at-
tention and are now used for monitoring purposes,
alignment of financial incentives [13, 29] and, in the
foreseeable future, in shared saving programs such as
the Alternative Quality Contract (AQC) [30]. In this
manner, low-value care measurement may incentivize
providers and insurers to shift resources from low-value
services to high-value services [31]. Our findings show
that more attention is needed for the evidential under-
pinning and quality of these measures. Otherwise, the
lack of transparency and evidence will reduce acceptance
of low-value care measures by its users. Additionally,
using measures of low quality, might lead to negative
consequences including underuse of indicated services,
cost-shifting, damages to the patient-physician relation-
ship, provider dissatisfaction, adverse health effects, or
patient selection [17].
Our review showed that more than half of the low-
value care measures originated from low-value service
recommendations (i.e. CW, NICE, USPSTF). This im-
plies that the empirical evidence of many low-value care
measures is based on the evidence supporting the under-
lying low-value service recommendations. However, cri-
teria for the development of recommendation lists
remains rather vague in the CW initiative, as well as in
other similar campaigns [7]. Therefore, more transpar-
ency regarding the evidential underpinning of the rec-
ommendations is needed. Next to the importance of
evidence underlying both low-value service recommen-
dations and measures, one should be aware that the aim
of low-value service recommendations differs from the
aim of low-value care measures. The aim of CW recom-
mendations is patient and physician awareness, while the
aim of low-value care measures in turn may be to inform
decisions on several levels. Consequently, requirements
for the quality and development of recommendations and
measures approaches vary accordingly.
We found that most current low-value care measures
are concentrated in the cure sector even though it was
argued that low-value services are provided and used
along the entire continuum of care [21]. For example,









Cervical cancer screening Imaging for sinusitis
diagnosis
Number of measures
included in review a
4 (measure no.:
42–44, 48)
7 (measure no.: 57–59,
62, 63, 65, 66)
8 (measure no.: 2–9) 3 (measure no.: 110–112) 4 (measure no.: 33, 35,
36, 59)
Measure criteria b
Face validity c Yes: level of evidence
is 2
Yes, level of evidence
is 1
Yes, level of evidence
is 1
Yes, level of evidence
is 2




Not found Not found Not found Not found Not found
Construct validity Not found Not found Not found Not found Not found











Yes, in Physician Quality
Reporting System [49]
Not found
a: Measure numbers corresponding with Additional file 2 between brackets
b: Criteria for quality measures (AHRQ)
c: For level of evidence also see Table 2
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we only found four low-value care recommendations (that
could possibly be transformed into low-value care mea-
sures) in rehabilitative care and none in the health promo-
tion domain. This is probably the result of most measures
originating from the CW initiative, which has its origin in
the cure sector. While we acknowledge the emerging state
of the field of research, we emphasize that similar
consensus-based efforts are needed to stimulate the devel-
opment of measures in other settings to broaden the
scope and impact of the low-value care concept.
Given the potential impact of using low-value care
measures, it is essential that guidelines for developing
them be created by combined efforts of the involved par-
ties: physicians, citizens, government and insurers [17,
32]. We do not suggest creating an evidence base for
each health care intervention demonstrating all circum-
stances in which it is not effective. This will prove an un-
doable exercise. Expert judgement by the clinician will
always remain necessary to some degree. Therefore,
other types of information, e.g. from studies on practice
variation in procedure rates or cost-effectiveness studies,
will remain necessary to identify inefficiencies in health-
care, especially when high quality low-value care mea-
sures are not available. We do propose using expert
opinion from initiatives such as Choosing Wisely as a
starting point for monitoring low-value care. These
qualitative information sources can be complemented
with new scientific insights. For example, the insight that
certain genes predict the development of breast cancer,
must be used to prevent a considerable amount of low-
value care utilization. Still, as soon as we start measuring
and monitoring low-value care in such areas, it will be
of particular interest to fully specify and define all meas-
urement information, such as exclusion criteria, direc-
tion and evidence supporting the measure, and to make
this publicly available. Furthermore, low-value care mea-
sures should be extensively tested regarding their level
of evidence and validity before implementing them for
use in practice, and specifically for the measures that are
already in use. Recently, articles started studying aspects
that are closely related to validity. As for example,
Schwartz et al. [2] who found that the sensitivity and
specificity strongly depends on the definition of the mea-
sures. Notwithstanding the efforts already been made,
we stress the importance of the validity of the measures
specifically being studied. Another area of research
would be to further standardize low-value care mea-
sures, which ideally would result in alignment of the
low-value care metrics and determining specifically for
what subgroup or population a service is of low-value [2,
33]. Moreover, the guidelines should take into account
any differences between countries in terms of the avail-
ability and provision of healthcare services that are likely
to occur due to cultural or economic differences.
Another important issue to pay further attention to is
the data requirements. Measuring low-value care
utilization requires information on services provided to
patients in combination with diagnosis and possibly
additional patient characteristics. It is not clear to
which extent current data sources can provide this in-
formation [2, 3], since rather detailed data need to be
registered and data sources, such as claims data and de-
tailed (hospital) registration data need to be connected
in order to retrieve the necessary information.
Limitations
Our study has two main limitations. First, we did not
evaluate the quality of each individual measure. Ideally,
we would extensively assess each measure regarding
their validity. To perform this task for 115 measures
was, however, beyond the scope of this review. Nonethe-
less, we performed a first attempt in assessing the valid-
ity for the five measures that appeared most often in the
literature and highlight several important general quality
issues. Second, we did not include grey literature in our
search. Therefore, we may have missed relevant mea-
sures. Nevertheless, for the purpose of our review,
namely to systematically map the state of affairs of low-
value care measurement, we are confident that the pub-
lications we did use provided sufficient evidence.
Conclusions
To conclude, our systematic review provides insight in
the current state of low-value care measures. It shows
that current low-value care measures only cover a select-
ive part of the health care system. To achieve their full
potential, future research should be focused on generat-
ing clear information about the level of evidence and
validity to identify measures that truly represent low-
value care in this emerging field of research. This will
contribute to creating and maintaining the support of
stakeholders who will use these measures for monitoring
purposes and innovative insurer-provider contracts, all
aiming to improve efficiency in health care with better
health outcomes.
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